Editorially reviewed by Dr Fatimah Khan, registered with the Pakistan Medical and Dental Council (PMDC no. 104595-P). Editorial medical reviewer; does not prescribe or review patient assessments.
Review details
Review recorded:
Review scope: This article edition.
Editorial reviewer for Prescrivia. Editorial review does not establish participation in patient consultations.
Clinical review does not replace individual medical advice. Prescrivia is a technology intermediary; independent doctors make clinical decisions.
Legal review: Qualified review pending.
Language review: Qualified review pending.
Source and review
Source published:
Attributed source update:
Text edited:
Editorial role: Editorial team. This description does not establish an individual credential or clinical review of this edition.
Read our editorial policy and corrections. Edit dates and source descriptions do not establish qualified review.
How does varenicline help you quit smoking?
Varenicline, known by brands including Champix, is a prescription smoking-cessation medicine for adults. It acts at nicotine receptors to reduce withdrawal symptoms and the rewarding effect of smoking. It does not guarantee that cravings disappear or that you will remain smoke-free.
A quit plan should cover medicine use, the target quit approach, triggers, behavioural support and follow-up. Nicotine's effects and learned smoking habits both matter when planning a quit attempt.
The course is an individual treatment plan
EMA information describes a usual twelve-week treatment course, with additional treatment considered for some people. Dose escalation and the quit strategy should follow the exact product and prescriber's plan.
Do not copy a dose ladder or add nicotine replacement yourself. If nausea or another side effect makes treatment difficult, ask about adjustment rather than abandoning the attempt or increasing the dose.
What the studies show
EMA's Champix overview summarises two main studies involving 2,052 smokers. Continuous abstinence during weeks 9–12 was approximately 44% with Champix, 30% with bupropion and 18% with placebo.
That endpoint is not the same as being permanently smoke-free after twelve weeks. Later abstinence measures answer a different question, and trial percentages do not predict an individual's result.
This guide does not extend those findings into a universal ranking against all nicotine-replacement combinations or apply an unsourced behavioural-support multiplier. Support remains useful for planning, adherence and responding to triggers.
Kidney function, pregnancy and breastfeeding
Kidney function can affect prescribing. EMA information does not require routine adjustment for mild or moderate impairment, but allows reduction if moderate impairment is accompanied by intolerable reactions. Severe impairment needs a different regimen; treatment is not recommended in end-stage renal disease. Age alone is not a complete dose-adjustment rule.
Tell the prescriber about kidney disease and recent renal tests. Do not reduce the dose yourself or assume any kidney impairment excludes treatment.
NHS advice does not recommend varenicline during pregnancy and generally advises alternatives during breastfeeding. Seek a clinician's or pharmacist's plan for quitting; nicotine replacement may be considered with professional advice.
Side effects and mental-health review
Nausea, sleep disturbance and abnormal dreams are recognised effects. Discuss troublesome symptoms and read the exact leaflet.
Tell the clinician about previous mental-health problems. If new or worsening agitation, depression, unusual behaviour or thoughts of self-harm develop, stop taking varenicline and contact a clinician immediately, as directed by the product information. Thoughts of suicide or immediate danger need emergency help. A treatment's overall study results cannot guarantee that an individual will have no psychiatric reaction.
Make follow-up practical
Ask what to do if you lapse, miss doses or cannot tolerate the medicine, and when the next review will be. A lapse does not make the whole attempt pointless.
The decision to prescribe or adjust treatment belongs to an independent clinician. A general guide cannot promise a particular brand, medicine supply or quit outcome.
Information and clinical decisions
This guide provides general information, not a diagnosis or personal treatment plan. Any clinical assessment and prescribing decision rests with an independent clinician. Prescrivia is a technology intermediary, not a medical provider or pharmacy; it does not prescribe, sell or dispense medicines. Assessment does not guarantee a prescription, medicine availability or a health outcome.
Further reading: treatment information.
Read about online consultations and their limits. Service information must not delay urgent local care.
Sources
- EMA: Champix — Adult smoking-cessation use, twelve-week course and continuous-abstinence weeks 9–12 results in 2,052 smokers.
- EMA: Champix product information — Renal-impairment distinctions, tolerability, interactions and neuropsychiatric safety instructions.
- NHS: varenicline in pregnancy and breastfeeding — Not recommended in pregnancy; generally prefer alternatives in breastfeeding with professional advice.
See the current clinical, legal and language review statuses for this edition. Source checks are editorial work, not approval.